Drug intelligence / Profile preview

Sanqi Shengban Tang

Development stage: Preclinical
Lead developer: Shanghai Municipal Health Commission
Administration: Oral

Overview

Sanqi Shengban Tang is a traditional Chinese herbal medicine, specifically a decoction, formulated as granule pieces. It is currently being investigated in clinical trials for its efficacy and safety in the management of Immune Thrombocytopenia.

Other names: 三七升板汤颗粒饮片SQSB decoctionChinese herbal granule pieces of SQSB decoction

Beyond the preview

Go deeper on Sanqi Shengban Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanqi Shengban Tang.

Explore the full profile